Last reviewed: July 11, 2026
Last updated: July 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide, the active compound in Mounjaro and compounded formulations, has not been studied extensively in pregnant patients, and animal studies show potential risks to fetal development. If you become pregnant while taking tirzepatide, stopping the medication and consulting your healthcare provider is the recommended first step. This guide walks you through what the evidence shows, how to plan ahead, and what support PlexusDx can offer during this transition.
What the Research Shows About Tirzepatide and Pregnancy
Tirzepatide is a dual GLP-1 and GIP receptor agonist approved for type 2 diabetes and chronic weight management in adults. Preclinical animal studies conducted during drug development revealed potential developmental effects, which is why tirzepatide carries a black box warning for pregnancy. These animal findings do not automatically predict human outcomes, but they do warrant caution and informed decision-making.
No large randomized controlled trials have enrolled pregnant patients taking tirzepatide, so clinical evidence in humans remains limited. The FDA classifies tirzepatide in Pregnancy Category C, meaning risk cannot be ruled out but also has not been definitively established in human pregnancy. This uncertainty is precisely why stopping the medication as soon as pregnancy is confirmed is the standard medical recommendation.
Immediate Steps to Take If You Become Pregnant
Your first action should be to contact your prescribing provider and inform them of the positive pregnancy test. Do not wait for a scheduled appointment—call your doctor's office the same day and explain that you are taking tirzepatide. Your provider may advise you to stop injections or oral doses immediately, depending on your specific clinical situation and how far along you are in your pregnancy.
Next, schedule an urgent obstetric appointment with your OB/GYN or maternal-fetal medicine specialist. Bring a list of all medications and supplements you are taking, including the dose and frequency of your tirzepatide. Your obstetrician will review your medical history, discuss the timing of conception, and outline prenatal monitoring that may be appropriate given your medication exposure.
PlexusDx patients who become pregnant should reach out to our clinical team to pause treatment and discuss safe discontinuation protocols. We do not require justification for stopping therapy and can coordinate with your obstetric provider if needed. Stopping tirzepatide does not require tapering in most cases—your doctor will advise you on the safest approach for your situation.
Planning for Pregnancy if You Are Currently on Tirzepatide
If you are thinking about becoming pregnant in the near future, the evidence-based approach is to discontinue tirzepatide before conception or as soon as pregnancy is confirmed. Discuss your family planning timeline with your prescriber during your next visit. If pregnancy is planned within the next 3–6 months, your doctor may recommend stopping tirzepatide now rather than waiting.
Alternative weight management and metabolic support strategies exist for patients who are pregnant or planning pregnancy. These may include structured nutrition counseling, safe physical activity programs, behavioral coaching, and close monitoring of blood sugar if you have diabetes. Your obstetrician can refer you to a maternal medicine nutritionist or diabetes educator who specializes in pregnancy care.
PlexusDx's Precision Peptide Genetic Test can inform your long-term weight and metabolic management strategy after pregnancy, allowing you to identify genetic pathways that influence your response to GLP-1 and other therapies. This personalized data becomes valuable once pregnancy and postpartum recovery are complete, helping you and your provider choose the most effective treatment when you resume therapy.
Weight Management After Pregnancy and Resuming Treatment
Postpartum weight loss and metabolic recovery occur on different timelines for every person. Most healthcare providers recommend waiting until after pregnancy is complete and, in many cases, after breastfeeding is finished before restarting tirzepatide or other GLP-1 therapies. Your OB/GYN and primary care provider will advise on the appropriate timing based on your individual circumstances.
When you are ready to resume compounded tirzepatide or explore other GLP-1 options, PlexusDx offers flexible enrollment with no long-term contracts or membership fees. Compounded Tirzepatide Injection starts at $289/mo (or $249/mo on the 6-month plan), and we serve all 50 states with no insurance required. If you completed the Precision Peptide Genetic Test before pregnancy, your genetic insights remain relevant and can guide your provider in choosing the dose and compound that best matches your peptide pathways.
Communication Between Your Medical Team and PlexusDx
Coordination between your obstetric provider, primary care physician, and PlexusDx ensures a smooth transition. When you notify us that you are pregnant, we will flag your account and cease all refills automatically. Our clinical team does not require medical records or explanations—your decision to pause therapy is sufficient.
If your healthcare provider has questions about PlexusDx compounded formulations, dosing, or the Precision Peptide Genetic Test, they can contact our provider support team directly. We maintain HIPAA-compliant communication and are happy to discuss your medical history and medication safety with your authorized physician. This collaborative approach puts your health and your baby's health first.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Should I stop taking tirzepatide immediately if I find out I'm pregnant?
Yes, contact your healthcare provider the same day you find out you are pregnant and inform them that you are taking tirzepatide. Your doctor will advise you on whether to stop immediately or follow a specific discontinuation plan. Do not continue injections or oral doses without explicit guidance from your prescriber.
What is the evidence that tirzepatide causes birth defects?
Animal studies during drug development showed potential developmental effects, which is why tirzepatide carries a pregnancy warning. However, no large controlled trials have studied tirzepatide in pregnant humans, so the exact risk in pregnancy remains unknown. This uncertainty is why discontinuing the medication as soon as pregnancy is confirmed is standard medical practice.
Can I take tirzepatide if I'm breastfeeding?
The amount of tirzepatide that passes into breast milk is not well established, and it is not recommended while breastfeeding. Most healthcare providers advise waiting until breastfeeding is complete before restarting tirzepatide or other GLP-1 medications. Discuss the timing with your OB/GYN and pediatrician.
How much does tirzepatide cost at PlexusDx, and what happens if I need to pause my subscription?
Compounded Tirzepatide Injection at PlexusDx starts at $289/mo (or $249/mo on the 6-month plan) with no membership fee or long-term contract required. If you become pregnant, you can pause your subscription at any time, and we will not charge you. When you are ready to resume after pregnancy and recovery, enrollment is simple and flexible.
What is the Precision Peptide Genetic Test, and can it help me plan my weight management after pregnancy?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to show how your body responds to GLP-1 and other weight-loss compounds. If you completed the test before pregnancy, your genetic data remains valid and will help guide your provider in selecting the most effective therapy when you resume treatment postpartum.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Mounjaro’s Timeline: How Soon Does Mounjaro Start Working for Weight Loss and Diabetes Management?
Does Where You Inject Mounjaro Matter? Understanding Injection Sites for Optimal Results